stockrowGSK PLC Sponsored ADR (GSK) vs Scilex Holding Company (SCLX)
- GSK PLC Sponsored ADR GSK 50.33 −0.16%
- Scilex Holding Company SCLX 1.70 0.00%
GSK PLC Sponsored ADR and Scilex Holding Company are both Drug Manufacturers General companies. GSK PLC Sponsored ADR is the larger, with a market value of $101.0B against $12.0M — 8448.2× the size. Scilex Holding Company has negative trailing earnings, so its P/E is not meaningful; GSK PLC Sponsored ADR trades at 16.7×. GSK PLC Sponsored ADR grew revenue faster over the last twelve months: 6.90% against −28.6%. GSK PLC Sponsored ADR has the higher net margin (13.0% vs −1,418.5%) and the higher return on invested capital (9.61% vs 0.00%). Across the 18 metrics below, GSK PLC Sponsored ADR leads on 13 and Scilex Holding Company on 5.
Valuation
Profitability
| Metric | GSK | SCLX | Drug Manufacturers General median |
|---|---|---|---|
| Gross margin | 72.64% | 55.50% | 73.01% |
| Operating margin | 17.95% | (1,136.40%) | 18.34% |
| Net margin | 13.02% | (1,418.45%) | 7.31% |
| Free cash flow margin | 19.65% | (56.37%) | 18.56% |
| Return on equity | 25.48% | 160.27% | 5.80% |
| Return on assets | 6.53% | (265.83%) | 2.28% |
| Return on invested capital | 9.61% | 0.00% | 6.26% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack